The popular female activist and US-based pharmacist, Kemi Olunloyo has announced that she may also be present in the upcoming rally, OccupyLekkiTollGate which was organized by some youths and human rights activists to seek justice for people who were allegedly shot during the EndSARS protest at the Lekki tollgate, the announcement was made through her Twitter handle.
Kemi Olunloyo has earlier complained about her swollen legs in one of her tweets, hoping for prayers from Nigerians. However, she opted to attend the rally despite her sickness as she said it will be her first street demonstration in Nigeria.
In her latest tweet, he said the government will not dare to block her bank account or order any soldier to shoot her during the rally and if so, the Central Bank of Nigeria (CBN) will be shut down.
See the tweets below;
Following her tweets, many Nigerians reacted differently as also shown below;
Is it not risky for Dr. Kemi Olunloyo to attend the OccupyLekkiTollGate rally with her sickness?
Content created and supplied by: Hertheyshiner (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform